Health
Rapid CD169 assay for COVID-19 screening – News-Medical.Net
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory…
Researchers in France have conducted a study demonstrating the sensitivity of a rapid flow cytometry assay that could be used to screen for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
The assay detects the upregulation of whole blood monocyte CD169, which has been reported as a marker of viral infections.
This rapid assay was more sensitive than the currently used method and less likely to produce false-negative results, especially among early and asymptomatic patients.
…
-
Noosa News11 hours agoPrincess Anne visits Gallipoli Barracks in Brisbane on Remembrance Day as Australian tour ends
-
General22 hours agoMillennials and Gen Z voters continued shift away from Coalition in 2025
-
Noosa News9 hours agoRoyal visit to Gallipoli Barracks in Enoggera on Remembrance Day
-
General11 hours ago‘Do you care?’: Coles stares down anti-salmon activists